The STEP 1 clinical trial showed participants on 2.4 mg semaglutide lost an average of 14.9% of body weight over 68 weeks

Seek immediate medical attention (contact 999 or attend A&E) if back pain is accompanied by: Severe, persistent abdominal pain radiating to the back, especially with nausea and vomiting (possible pancreatitis) Loss of bladder or bowel control (potential cauda equina syndrome) Numbness or weakness in both legs (neurological emergency) Fever, unexplained weight loss, or night sweats (possible infection or malignancy) History of trauma or significant injury preceding the pain Contact NHS 111 or your GP or diabetes specialist nurse within 24-48 hours if: Back pain is new, persistent, or progressively worsening since starting Rybelsus Pain significantly interferes with daily activities or sleep You experience unexplained symptoms alongside back pain, such as persistent nausea, changes in bowel habits, or urinary symptoms Pain does not improve with simple analgesia or rest after several days You have concerns about continuing Rybelsus due to the discomfort You develop right upper abdominal pain radiating to the back or shoulder, possibly with fever or jaundice (potential gallbladder disease) According to NICE guideline NG59 on low back pain assessment, healthcare professionals should conduct a thorough history and examination to identify any red flag features suggesting serious pathology

This clinical comparison breaks down when to choose one over the other, what each does for energy, muscle, and brain function, and what happens when patients use both
Until now, it was believed that pancreatic alpha cells were only able to produce glucagon, a hormone that helps to raise blood sugar levels when our bodies require energy, for example, during fasting or exercising
Preparing Your Body Before Stopping Mounjaro If you and your doctor decide to discontinue Mounjarowhether for medical reasons, access issues, or other circumstancesplanning your transition matters
Ultimately, this represents a shared cost-benefit decision that patients and clinicians should be comfortable exploring. References 1